ECM Therapeutics secures FDA approval for first-of-its-kind study one year after significant capital raise

  • Stephen Badylak

Press/Media

Period6 May 2025

Media coverage

1

Media coverage

  • TitleECM Therapeutics secures FDA approval for first-of-its-kind study one year after significant capital raise
    Media name/outletPittsburgh Business Times (Pittsburgh, PA)
    Country/TerritoryUnited States
    Date6/05/25
    PersonsStephen Badylak